欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0268/001
药品名称Porcilis Ery+Parvo+Lepto
活性成分
    • erysipelothrix rhusiopathiae 1.0 ppd
    • leptospira interrogans serogroup canicola 1408.0 U/ml
    • leptospira interrogans serogroup icterohaemorragiae 105.0 U/ml
    • Leptospira kirschneri serogroup Grippotyphosa 324.0 U/ml
    • porcine parvovirus 65.0 U/ml
剂型Suspension for injection
上市许可持有人Intervet International B.V. Wim de Körverstraat 35 P.O. Box 31 5830 AA Boxmeer The Netherlands
参考成员国 - 产品名称Germany (DE)
Porcilis Ery+Parvo+Lepto
互认成员国 - 产品名称
    • Denmark (DK)
      Porcilis Ery + Parvo + Lepto
    • Belgium (BE)
      Porcilis Ery+Parvo+Lepto
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
      Porcilis Ery+Parvo+Lepto
    • Ireland (IE)
    • Austria (AT)
      Porcilis Ery+Parvo+Lepto Injektionssuspension für Schweine
    • France (FR)
      PORCILIS ERY + PARVO + LEPTO
    • Spain (ES)
      PORCILIS ERY+PARVO+LEPTO SUSPENSION INYECTABLE PARA PORCINO
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
      Porcilis Ery+Parvo+Lepto injekční suspenze pro prasata
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2016/07/27
最近更新日期2023/10/17
药物ATC编码
    • QI09AL07 porcine parvovirus + erysipelothrix + leptospira
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase